Agilent Technologies, Inc. (A) Stock Price & Analysis
Agilent Technologies, Inc. (A) rose 2.10% to USD 135.48 as of June 9, 2026 at 22:36 UTC, according to Nexqual real-time market data.
A last closed at USD 132.69; the session ranged USD 134.43–137.64 on volume of 1,495,546 shares. Market capitalization is $38.26B, with a 52-week range of USD 108.35–160.27 (NYQ). Source: Nexqual, June 9, 2026 at 22:36 UTC.
Key Statistics (as of June 9, 2026 at 22:36 UTC)
| Price | USD 135.48 |
|---|---|
| Change | ▲ 2.10% (up) |
| Previous Close | USD 132.69 |
| Open | USD 134.25 |
| Day Range | USD 134.43 – 137.64 |
| 52-Week Range | USD 108.35 – 160.27 |
| Volume | 1,495,546 shares |
| Market Cap | $38.26B |
| Exchange | NYQ |
Technical Analysis (A)
Nexqual's technical model rates A "BUY" based on 5 bullish and 1 bearish signals across 124 daily candles, as of June 9, 2026 at 22:36 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 65.1 (neutral) |
| vs SMA50 | Above (USD 119.15) |
| MACD | 5.64 (positive) |
Analyst Ratings (A)
Wall Street analysts rate A "Strong Buy" based on 16 analysts, with a mean price target of USD 161 (range USD 144–185), per Nexqual as of June 9, 2026 at 22:36 UTC.
| Consensus Rating | Strong Buy |
|---|---|
| Analyst Count | 16 |
| Mean Target | USD 161 |
| High Target | USD 185 |
| Low Target | USD 144 |
| Buy / Hold / Sell | 16 / 2 / 0 |
Earnings (A)
| Next Earnings Date | 2026-08-26 |
|---|---|
| EPS Estimate | USD 1.49 |
| Revenue Estimate | $1.84B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-04-30 | USD 1.49 vs est 1.41 ▲ beat |
| 2026-01-31 | USD 1.36 vs est 1.37 ▼ miss |
| 2025-10-31 | USD 1.59 vs est 1.58 ▲ beat |
| 2025-07-31 | USD 1.37 vs est 1.37 ▲ beat |
Source: Nexqual, June 9, 2026 at 22:36 UTC.
Financials & Fundamentals (A)
| Total Revenue | $7.23B |
|---|---|
| Revenue Growth (YoY) | +10.00% |
| Gross Margin | +52.64% |
| Operating Margin | +23.71% |
| Profit Margin | +19.55% |
| ROE | +21.33% |
| Debt / Equity | 49.73 |
| Current Ratio | 2.1 |
| Total Cash | $1.81B |
| Total Debt | $3.54B |
| Free Cash Flow | $930.63M |
Source: Nexqual, June 9, 2026 at 22:36 UTC.
Financial Health Score (A)
Nexqual rates Agilent Technologies, Inc.'s overall financial health "Solid" across five dimensions, as of June 9, 2026 at 22:36 UTC.
| Growth | Solid — Revenue +7% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 53%, operating 24% |
| Balance Sheet | Strong — $1.81B cash vs $3.54B debt |
| Cash Flow | Solid — FCF $931M, 13% margin |
| Efficiency | Strong — ROE 21%, ROA 8.6% |
Ownership (A)
| Insider Ownership | +0.19% |
|---|---|
| Institutional Ownership | +94.10% |
| Shares Outstanding | 282.43M |
| Float | 281.46M |
| Short % of Float | +2.22% |
Source: Nexqual, June 9, 2026 at 22:36 UTC.
Leadership (A)
Agilent Technologies, Inc. is led by Padraig McDonnell (age 53), CEO, President & Director, per Nexqual as of June 9, 2026 at 22:36 UTC.
| CEO, President & Director | Padraig McDonnell (age 53) |
|---|---|
| Senior VP & President of Agilent CrossLab Group | Angelica A. Riemann (age 54) |
| Senior VP and President of Life Sciences & Diagnostics Markets Group | Simon May (age 52) |
| Senior VP, CFO & Principal Financial Officer | Adam S. Elinoff (age 47) |
| Senior VP & Chief Technology Officer | August Specht |
Major Backers & Investors (A)
Notable institutional backers of Agilent Technologies, Inc. include T. Rowe Price, Massachusetts Financial Services Co., Wellington Management, according to Nexqual as of June 9, 2026 at 22:36 UTC.
Active Investors
| Investor | Stake |
|---|---|
| T. Rowe Price | 4.69% |
| Massachusetts Financial Services Co. | 4.47% |
| Wellington Management | 2.57% |
| Morgan Stanley | 1.75% |
| Fidelity | 1.28% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 21.63% |
| BlackRock | 10.47% |
| State Street | 5.72% |
| Geode Capital | 2.66% |
| Deutsche Bank AG | 2.12% |
Source: Nexqual, June 9, 2026 at 22:36 UTC.
From Agilent Technologies, Inc.'s Latest SEC 10-K Filing (filed 2025-12-22)
Key Strengths & Strategy (as disclosed to the SEC)
- Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
- The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets.
- The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems.
- This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| KEYS | Keysight Technologies Inc. | USD 331.43 | ▲ 0.49% |
| HPQ | HP Inc. | USD 24.94 | ▼ 2.5% |
| ADI | Analog Devices, Inc. | USD 404.62 | ▲ 0.8% |
| TMO | Thermo Fisher Scientific Inc | USD 494.07 | ▲ 4.5% |
| DHR | Danaher Corporation | USD 188.41 | ▲ 2.23% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 9, 2026 at 22:36 UTC. This page is informational and not investment advice.